Reference number: OPUSeJ 201301161132HLD
Title: How Long Does a Cough Last? Comparing Patients’ Expectations; With Data From a Systematic Review of the Literature
Authors: Ebell, M H, Lundgren, J & Youngpairoj, S
PURPOSE: We hypothesized that antibiotic overuse for acute cough illness (ACI) is in part due to a mismatch between patients’ expectations and the natural history of ACI.
METHODS: We performed a population-based random digit dialing survey of 493 adults in Georgia to determine their expectations regarding the duration of ACI. We also performed a systematic review of observational studies and the placebo or untreated control groups of randomized controlled trials to determine the duration of ACI from the published medical literature. We included studies of otherwise healthy adults with undifferentiated ACI, no clear bacterial cause, data on at least 1 cough outcome, and at least 1 week of follow-up.
RESULTS: The mean duration of cough in the published literature was 17.8 days. Survey respondents reported a median duration of 5 to 7 days and a mean duration of 7.2 to 9.3 days depending on the specific scenario. Patients expecting a longer duration of illness were more likely to be white, female, and have self-reported asthma or chronic lung disease. Independent predictors of the belief that antibiotics are always helpful included nonwhite race (OR = 1.82, 95% CI, 1.14–2.92), some college education or less (OR = 2.08, 95% CI, 1.26–3.45), and previous antibiotics for ACI (OR = 2.20, 95% CI, 1.34–3.55).
CONCLUSIONS: There is a mismatch between patients’ expectations regarding the duration of ACI and the actual duration based on the best available evidence. Efforts to reduce inappropriate antibiotic use should target this discrepancy.
Mark H Ebell (TBA)
Jerold Lundgren (TBA)
Surasak Youngpairoj (TBA)
Mark H Ebell: Department of Epidemiology and Biostatistics, College of Public Health, The University of Georgia, Athens, Georgia and Institute for Evidence-Based Practice in the Health Professions, College of Public Health, The University of Georgia, Athens, Georgia.
Jerold Lundgren: Franklin College, The University of Georgia, Athens, Georgia.
Surasak Youngpairoj: College of Public Health, The University of Georgia, Athens, Georgia.
Keywords: anti-bacterial agents; drug resistance; bacterial; bronchitis; cough; natural history
Arroll B, Kenealy T, Kerse N. Do delayed prescriptions reduce the use of antibiotics for the common cold? A single-blind controlled trial. J Fam Pract. 2002;51(4):324–328.
Brickfield FX, Carter WH, Johnson RE. Erythromycin in the treatment of acute bronchitis in a community practice. J Fam Pract. 1986;23(2):119–122.
Butler CC, Hood K, Kelly MJ, et al. Treatment of acute cough/lower respiratory tract infection by antibiotic class and associated outcomes: a 13 European country observational study in primary care. J Antimicrob Chemother. 2010;65(11):2472–2478.
Cals JWL, Boumans D, Lardinois RJM, et al. Public beliefs on antibiotics and respiratory tract infections: an internet-based questionnaire study. Br J Gen Pract. 2007;57(545):942–947.
Centers for Disease Control and Prevention. Get Smart campaign Web site. http://www.cdc.gov/getsmart/.
Chuchalin AG, Berman B, Lehmacher W. Treatment of acute bronchitis in adults with a Pelargonium sidoides preparation (EPs 7630): a randomized, double-blind, placebo-controlled trial. Explore (NY). 2005;1(6):437–445.
Dunlay J, Reinhardt R, Roi LDA. A placebo-controlled, double-blind trial of erythromycin in adults with acute bronchitis. J Fam Pract. 1987;25(2):137–141.
Grijalva CG, Nuorti J P,, Griffin MR. Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings. JAMA. 2009;302(7):758–766. CrossRefMedline Schappert SM, Rechtsteiner EA. Ambulatory medical care utilization estimates for 2007. National Center for Health Statistics. Vital Health Stat. 2011;13(169).
Hay AD, Wilson AD. The natural history of acute cough in children aged 0 to 4 years in primary care: a systematic review. Br J Gen Pract. 2002;52(478):401–409.
Hay AD, Wilson A, Fahey T, Peters TJ. The duration of acute cough in preschool children presenting to primary care: a prospective cohort study. Fam Pract. 2003;20(6):696–705.
Hueston WJ. Albuterol delivered by metered-dose inhaler to treat acute bronchitis. J Fam Pract. 1994;39(5):437–440.
Kemmerich B. Evaluation of efficacy and tolerability of a fixed combination of dry extracts of thyme herb and primrose root in adults suffering from acute bronchitis with productive cough. A prospective, double-blind, placebo-controlled multicentre clinical trial. [Drug Research]. Arzneimittelforschung. 2007;57(9):607–615.
King DE, Williams WC, Bishop L, Shechter A. Effectiveness of erythromycin in the treatment of acute bronchitis. J Fam Pract. 1996;42(6):601–605.
Littenberg B, Wheeler M, Smith DS. A randomized controlled trial of oral albuterol in acute cough. J Fam Pract. 1996;42(1):49–53.
Little P, Rumsby K, Kelly J, et al. Information leaflet and antibiotic prescribing strategies for acute lower respiratory tract infection: a randomized controlled trial. JAMA. 2005;293(24):3029–3035.
Macfarlane J, Holmes W, Gard P, Thornhill D, Macfarlane R, Hub-bard R. Reducing antibiotic use for acute bronchitis in primary care: blinded, randomised controlled trial of patient information leaflet. BMJ. 2002;324(7329):91–94.
Matthys H, de Mey C, Carls C, Rys A, Geib A, Wittig T. Effiacy and tolerability of myrtol standardized in acute bronchitis: a multi-centre, randomised, double-blind, placebo-controlled parallel group trial vs cefuroxime and ambroxol. Arzneimmittelforschung. 2000;50(8):700–711.
Matthys H, Eisebitt R, Seith B, Heger M. Efficacy and safety of an extract of Pelargonium sidoides (EPs 7630) in adults with acute bronchitis. A randomised, double-blind, placebo-controlled trial. Phytomedicine. 2003;10(Suppl 4):7–17.
Matthys H, Funk P. EPs 7630 improves acute bronchitic symptoms and shortens time to remission. Results of a randomised, double-blind, placebo-controlled, multicentre trial. Planta Med. 2008;74(6):686–692.
Matthys H, Heger M. Treatment of acute bronchitis with a liquid herbal drug preparation from Pelargonium sidoides (EPs 7630): a randomised, double-blind, placebo-controlled, multicentre study. Curr Med Res Opin. 2007;23(2):323–331.
Matthys H, Lizogub VG, Malek FA, Kieser M. Efficacy and tolerability of EPs 7630 tablets in patients with acute bronchitis: a randomised, double-blind, placebo-controlled dose-finding study with a herbal drug preparation from Pelargonium sidoides. Curr Med Res Opin. 2010;26(6):1413–1422.
Nduba VN, Mwachari CW, Magaret AS, et al. Placebo found equivalent to amoxicillin for treatment of acute bronchitis in Nairobi, Kenya: a triple blind, randomised, equivalence trial. Thorax. 2008;63(11):999–1005.
Phillips TG, Hickner J. Calling acute bronchitis a chest cold may improve patient satisfaction with appropriate antibiotic use. J Am Board Fam Pract. 2005;18(6):459–463.
Scherl ER, Riegler SL, Cooper JK. Doxycycline in acute bronchitis: a randomized double-blind trial. J Ky Med Assoc. 1987;85(9):539–541.
Stott NCH, West RR. Randomised controlled trial of antibiotics in patients with cough and purulent sputum. Br Med J. 1976;2(6035):556–559.
Verheij TJM, Hermans J, Mulder JD. Effects of doxycycline in patients with acute cough and purulent sputum: a double blind placebo controlled trial. Br J Gen Pract. 1994;44(386):400–404.
Williamson HA Jr.A randomized, controlled trial of doxycycline in the treatment of acute bronchitis. J Fam Pract. 1984;19(4):481–486.
Wilson AA, Crane LA, Barrett PH, Gonzales R. Public beliefs and use of antibiotics for acute respiratory illness. J Gen Intern Med. 1999;14(11):658–662.
Academic citations forward:
1) Ebell, M H, Lundgren, J & Youngpairoj, S, 2013, “How Long Does a Cough Last? Comparing Patients’ Expectations; With Data From a Systematic Review of the Literature”, Ann Fam Med 11:1, 5-13. doi: 10.1370/afm.1430. http://www.annfammed.org/content/11/1/5.full.